Medical Monitoring | Medical XPRT
Articles & Whitepapers
-
A breath screen for active tuberculosis at the point-of-care
Tuberculosis (TB) is on the rise, and traditional technologies are not up to the task of containing this fast-spreading disease. But a fast, robust, and low-cost optical system is enabling point-of-care testing Driven by various social factors, a number of “old” diseases have recently reemerged to significantly threaten world health. Of particular concern is the increase in ...
-
CanaQuest Medical Corp (OTC: CANQF)
About: CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid ...
News
-
Mojo Vision Reaches Significant Development Milestone for Smart Contact Lens
New prototype of Mojo Lens incorporates numerous industry-first features, including the world’s smallest and densest dynamic display, low-latency communication, and an eye-controlled user interface SARATOGA, Calif.--(March 30, 2022)--Mojo ...
Mobile Mammography
RTsafe’s core role for the development of German guidelines for a standard, safe and efficient implementation of Single-Isocentric Multi-Focal SRS throughout the country
Koning Ends the Year with $2.6M Republic Raise
Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders
Equipment & Solutions
-
Showcase
Metal Halide Light Source
The MS-24 metal halide light is one of the best solutions to complete routine inspections using rigid borescopes and/or fiberscopes. The design is portable and light weight with great output intensity (up to 150,000 Lux) with stable “white” color temperature. Due to the short metal halide arc lamp, the light acceptance of small fiber bundles is increased. Each bulb also has an average ...
Upcoming Events
-
Showcase
TIDES Europe 2022
Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.
